BRAF and neoplasm: Moreover, the BRAF inhibitor inhibits tumor growth by inhibiting the ERK pathway, and this in turn inhibits the negative feedback inhibition of ERK on RAS, which partially restores RAS activity, leading to the formation of BRAFV600E dimers induced by RAF [29].